Product Information
DARIFENACIN ER 7.5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.5115 per EA under NDC 65862086130. Its NADAC has been published 460 times since Nov 2, 2016.
FDA first approved this application on Sep 19, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Darifenacin market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
7.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862086130
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/20/2025
Active Ingredients
DARIFENACIN HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206743FDA Approved
9/19/2016
TE Code
AB
On Market Since
9/19/2016
Pharmacological Classes
Price Statistics
The NADAC for DARIFENACIN ER 7.5 MG TABLET has been published 460 times since Nov 2, 2016, and over the history we have for it it has declined 93.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5115 per EA |
|---|---|
| All-time high | $7.9955 (Nov 16, 2016) |
| All-time low | $0.5115 (Aug 20, 2025) |
| Median price | $1.9094 |
| Average price | $2.9062 |
| Largest weekly change | +76.3% (May 22, 2019) |
| Weeks tracked | 460 |
| Tracking since | Nov 2, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-44.8%
5Y
-80.9%
All
-93.6%
Last surveyed Aug 20, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DARIFENACIN ER 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DARIFENACIN ER 7.5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.5115 per EA (NDC 65862086130), effective Aug 20, 2025.
How has the price of DARIFENACIN ER 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for DARIFENACIN ER 7.5 MG TABLET has declined 93.6%. It has been tracked across 460 weekly CMS publications since Nov 2, 2016.
What are the highest and lowest recorded NADAC prices for DARIFENACIN ER 7.5 MG TABLET?
Since Nov 2, 2016, the NADAC for DARIFENACIN ER 7.5 MG TABLET has ranged from a low of $0.5115 (Aug 20, 2025) to a high of $7.9955 (Nov 16, 2016), with a median of $1.9094 per EA.
Are there cheaper alternatives to DARIFENACIN ER 7.5 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DARIFENACIN ER 7.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DARIFENACIN ER 7.5 MG TABLET?
DARIFENACIN ER 7.5 MG TABLET (NDC 65862086130) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.